Fibrobiologics Inc (FBLG)

09:12 AM

Top Executive Makes Bold Move Into FibroBiologics Stock - TipRanks

09:12 AM

03:04 AM

FibroBiologics completes site onboarding for diabetic ulcer trial - Investing.com

03:04 AM

12:51 PM

FibroBiologics completes site onboarding for diabetic ulcer trial By Investing.com - Investing.com Nigeria

12:51 PM

08:59 AM

FibroBiologics (FBLG) CSO Khoja buys $11k in stock - Investing.com

08:59 AM

08:40 AM

FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - The Manila Times

08:40 AM

08:30 AM

Fibroblast therapy moves toward Phase 1/2 trial for diabetic foot ulcers - Stock Titan

08:30 AM

02:41 AM

CEO Doubles Down on FibroBiologics With Bold Insider Stock Purchase - TipRanks

02:41 AM

Mar 04, 2026

CFO’s Bold Insider Buy Sparks Fresh Buzz Around FibroBiologics Stock - TipRanks

Mar 04, 2026

Mar 03, 2026

Davis Jason, FibroBiologics CFO, buys $28973 in FBLG stock By Investing.com - Investing.com Australia

Mar 03, 2026

Mar 03, 2026

Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them - Benzinga

Mar 03, 2026

Mar 03, 2026

Davis Jason, FibroBiologics CFO, buys $28973 in FBLG stock - Investing.com

Mar 03, 2026

Mar 03, 2026

FibroBiologics (FBLG) CFO purchases 70,000 shares in open-market trade - Stock Titan

Mar 03, 2026

Mar 02, 2026

Insider Makes Bold New Bet on FibroBiologics Stock - TipRanks

Mar 02, 2026

Mar 02, 2026

FBLG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026

Mar 02, 2026

FibroBiologics Jumps 22% On New Osteoporosis Patent, Stock Up - Nasdaq

Mar 02, 2026

Mar 02, 2026

Garcia Ruben A, FibroBiologics general counsel, buys $13k in FBLG - Investing.com

Mar 02, 2026

Mar 02, 2026

FibroBiologics receives patent for osteoporosis cell therapy - Investing.com

Mar 02, 2026

Mar 02, 2026

Garcia Ruben A, FibroBiologics general counsel, buys $13k in FBLG By Investing.com - Investing.com South Africa

Mar 02, 2026

Mar 02, 2026

FibroBiologics, Inc. announces issuance of U.S. patent covering fibroblast cell therapy for the treatment of osteoporosis - marketscreener.com

Mar 02, 2026

Mar 02, 2026

Fibrobiologics, Inc. Announces Issuance Of U.S. Patent Covering Fibroblast Cell Therapy For The Treatment Of Osteoporosis - TradingView

Mar 02, 2026

Mar 02, 2026

New fibroblast cell therapy patent targets osteoporosis - Stock Titan

Mar 02, 2026

Mar 02, 2026

FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis - Sahm

Mar 02, 2026

Feb 27, 2026

FBLG: Ready to Transition to Clinical-Stage Company - Smartkarma

Feb 27, 2026

Feb 27, 2026

FBLG Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026

Feb 26, 2026

FibroBiologics to Present at the BIO Investment & Growth Summit - Bitget

Feb 26, 2026

Feb 26, 2026

H.C. Wainwright cuts FibroBiologics stock price target to $4 By Investing.com - Investing.com Canada

Feb 26, 2026

Feb 26, 2026

H.C. Wainwright cuts FibroBiologics stock price target to $4 - Investing.com Nigeria

Feb 26, 2026

Feb 24, 2026

FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update - Bitget

Feb 24, 2026

Feb 24, 2026

FibroBiologics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Feb 24, 2026

Feb 24, 2026

FibroBiologics (FBLG) expands fibroblast-based cell therapy pipeline - Stock Titan

Feb 24, 2026

Feb 23, 2026

FibroBiologics gets Nasdaq extension to meet listing rules - Investing.com Australia

Feb 23, 2026

Feb 23, 2026

FibroBiologics gets Nasdaq extension to meet listing rules By Investing.com - Investing.com South Africa

Feb 23, 2026

Feb 23, 2026

FibroBiologics Shareholders Approve Reverse Split, Warrant Issuances - TipRanks

Feb 23, 2026

Feb 23, 2026

FibroBiologics shareholders approve reverse stock split and warrant share issuances - Investing.com Nigeria

Feb 23, 2026

Feb 23, 2026

FibroBiologics (NASDAQ: FBLG) investors approve reverse split and warrant shares - Stock Titan

Feb 23, 2026

Feb 23, 2026

FibroBiologics Granted Extension by Nasdaq to Regain Compliance - Bitget

Feb 23, 2026

Feb 18, 2026

FBLG PE Ratio & Valuation, Is FBLG Overvalued - Intellectia AI

Feb 18, 2026

Feb 17, 2026

Weekly Recap: Is FibroBiologics Inc stock overvalued or fairly pricedJuly 2025 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn

Feb 17, 2026

Feb 14, 2026

Analysis Recap: Is FibroBiologics Inc. benefiting from interest rate changesJuly 2025 Earnings & Real-Time Market Sentiment Reports - mfd.ru

Feb 14, 2026

Feb 14, 2026

How FibroBiologics Inc. stock reacts to inflationary pressuresJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - mfd.ru

Feb 14, 2026

Feb 14, 2026

Should I add FibroBiologics Inc. stock to my portfolio2025 Earnings Impact & AI Based Buy/Sell Signal Reports - mfd.ru

Feb 14, 2026

Feb 13, 2026

FBLG Should I Buy - Intellectia AI

Feb 13, 2026

Feb 11, 2026

Aug Drivers: Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Long-Term Safe Investment Plans - baoquankhu1.vn

Feb 11, 2026

Feb 11, 2026

What’s the fair value of FibroBiologics Inc. stockJuly 2025 Recap & Daily Profit Focused Screening - mfd.ru

Feb 11, 2026

Feb 10, 2026

FibroBiologics CEO Pete O’Heeron to Speak at A4LI's H-SPAN Summit on Longevity Science - Quiver Quantitative

Feb 10, 2026

Feb 10, 2026

Longevity policy summit taps FibroBiologics CEO for main stage talk - Stock Titan

Feb 10, 2026

Feb 09, 2026

Is FibroBiologics Inc. benefiting from interest rate changesJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru

Feb 09, 2026

Feb 06, 2026

FibroBiologics Faces Nasdaq Delisting Review After Noncompliance - TipRanks

Feb 06, 2026

Feb 06, 2026

FibroBiologics Received Notice of Delisting - TradingView

Feb 06, 2026

Feb 05, 2026

FibroBiologics Secures Canadian Patent for Innovative Cachexia Treatment Using Fibroblast Cells - Quiver Quantitative

Feb 05, 2026

Feb 05, 2026

FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia - ChartMill

Feb 05, 2026

Jan 28, 2026

FibroBiologics (NASDAQ:FBLG) Shares Down 1.6% – What’s Next? - Defense World

Jan 28, 2026